BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34216697)

  • 1. Expression of insulinoma-associated protein 1 in non-small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors.
    Wang M; Abi-Raad R; Baldassarri R; Adeniran AJ; Cai G
    Hum Pathol; 2021 Sep; 115():104-111. PubMed ID: 34216697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma.
    Tsai HK; Hornick JL; Vivero M
    Mod Pathol; 2020 Aug; 33(8):1571-1580. PubMed ID: 32203089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears.
    Nakra T; Nambirajan A; Guleria P; Phulware RH; Jain D
    Cancer Cytopathol; 2019 Aug; 127(8):539-548. PubMed ID: 31343851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.
    Mukhopadhyay S; Dermawan JK; Lanigan CP; Farver CF
    Mod Pathol; 2019 Jan; 32(1):100-109. PubMed ID: 30154579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: Validity and reliability with cutoff value.
    Abe H; Takase Y; Sadashima E; Fukumitsu C; Murata K; Ito T; Kawahara A; Naito Y; Akiba J
    Cancer Cytopathol; 2019 Sep; 127(9):598-605. PubMed ID: 31436913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
    Doxtader EE; Mukhopadhyay S
    Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts.
    González I; Lu HC; Sninsky J; Yang C; Bishnupuri K; Dieckgraefe B; Cao D; Chatterjee D
    Histopathology; 2019 Oct; 75(4):568-577. PubMed ID: 31077609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
    Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
    Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
    Chen JF; Yang C; Sun Y; Cao D
    Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma.
    Lilo MT; Chen Y; LeBlanc RE
    Am J Surg Pathol; 2018 Nov; 42(11):1541-1548. PubMed ID: 30080705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CytoLyt fixation impedes insulinoma-associated protein 1 (INSM1) immunoreactivity compared to formalin fixation.
    Garlin-Politis M; Upadhyay Baskota S; Picon S; Collins N; Virk RK; Cimic A; Yousefi E; Gonzalez A
    J Am Soc Cytopathol; 2024; 13(3):213-218. PubMed ID: 38575468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The panel of syntaxin 1 and insulinoma-associated protein 1 outperforms classic neuroendocrine markers in pulmonary neuroendocrine neoplasms.
    Zombori T; Turkevi-Nagy S; Sejben A; Juhász-Nagy G; Cserni G; Furák J; Tiszlavicz L; Krenács L; Kővári B
    APMIS; 2021 Apr; 129(4):186-194. PubMed ID: 33417719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56.
    Kriegsmann K; Zgorzelski C; Kazdal D; Cremer M; Muley T; Winter H; Longuespée R; Kriegsmann J; Warth A; Kriegsmann M
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):237-242. PubMed ID: 30358615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.
    Hou T; Gan Q; Joseph CT; Sun X; Gong Y
    Cancer Cytopathol; 2020 Oct; 128(10):725-732. PubMed ID: 32573984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
    Seijnhaeve E; Galant C; Van Bockstal MR
    Int J Surg Pathol; 2021 Aug; 29(5):496-502. PubMed ID: 33426999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens.
    Viswanathan K; Siddiqui MT; Borczuk AC
    J Am Soc Cytopathol; 2019; 8(6):299-308. PubMed ID: 31345782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinoma-associated Protein 1 Expression and Its Diagnostic Significance in Female Genital Tract Neuroendocrine Carcinomas.
    Ting CH; Wang TY; Wu PS
    Int J Gynecol Pathol; 2021 Sep; 40(5):452-459. PubMed ID: 33323849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
    Zou Q; Zhang L; Cheng Z; Guo X; Cao D
    Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma.
    Yuan C; Jiao F; Zhai C; Zhang J; Wang S; Zhu L
    Laryngoscope; 2021 Oct; 131(10):E2662-E2668. PubMed ID: 33847383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract.
    Kim IE; Amin A; Wang LJ; Cheng L; Perrino CM
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):687-693. PubMed ID: 31876605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.